Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) - Total Liabilities

Latest as of March 2026: CN¥717.55 Million CNY ≈ $105.00 Million USD

Based on the latest financial reports, Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) has total liabilities worth CN¥717.55 Million CNY (≈ $105.00 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. - Total Liabilities Trend (2016–2025)

This chart illustrates how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. See Shandong Bailong Chuangyuan Bio-Tech Co. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Competitors by Total Liabilities

The table below lists competitors of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. ranked by their total liabilities.

Company	Country	Total Liabilities
Yinbang Clad Material SHE:300337	China	CN¥5.78 Billion
Alkane Resources Ltd AU:ALK	Australia	AU$382.43 Million
Xinjiang Zhongtai Chemical Co Ltd SHE:002092	China	CN¥52.74 Billion
Poly Plastic Masterbatch Suzhou Co SHE:300905	China	CN¥285.28 Million
Monte Rosa Therapeutics Inc NASDAQ:GLUE	USA	$214.51 Million
Vaisala Oyj A HE:VAIAS	Finland	€270.30 Million
Triumph Financial, Inc. NYSE:TFIN	USA	$5.93 Billion
Yutong Optical SHE:300790	China	CN¥3.30 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Shandong Bailong Chuangyuan Bio-Tech Co. stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.51	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.34	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2025)

The table below shows the annual total liabilities of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥475.19 Million ≈ $69.54 Million	+42.16%
2024-12-31	CN¥334.27 Million ≈ $48.91 Million	+35.69%
2023-12-31	CN¥246.35 Million ≈ $36.05 Million	+93.99%
2022-12-31	CN¥126.99 Million ≈ $18.58 Million	+60.65%
2021-12-31	CN¥79.05 Million ≈ $11.57 Million	-45.45%
2020-12-31	CN¥144.91 Million ≈ $21.20 Million	-7.87%
2019-12-31	CN¥157.28 Million ≈ $23.01 Million	+45.50%
2018-12-31	CN¥108.09 Million ≈ $15.82 Million	-42.92%
2017-12-31	CN¥189.38 Million ≈ $27.71 Million	-29.64%
2016-12-31	CN¥269.14 Million ≈ $39.38 Million	--

About Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.

SHG:605016 China Packaged Foods

Market Cap

$1.55 Billion

CN¥10.56 Billion CNY

Market Cap Rank

#7250 Global

#1661 in China

Share Price

CN¥25.15

Change (1 day)

-0.36%

52-Week Range

CN¥18.88 - CN¥28.42

All Time High

CN¥29.93